Evaluation reports aim to give objective information and guidance on medicines and medical devices to commissioners of health services, prescribers and others. They include efficacy, adverse effects, place in treatment and arrangements for prescribing.
Xonvea® is the only drug specifically licensed in the UK for the treatment of nausea and vomiting in pregnancy. It is intended for use in women with symptoms of nausea and vomiting in pregnancy that do not respond to conservative management.
This review is older than 18 months; in view of the continued emergence of new evidence, readers are recommended to re-check the biomedical literature.